TAMIKA SPADY: Open Payments
NPI 1982145165 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$112 in 5 payments from 3 companies in 2025. Trend: 2023 $246 · 2024 $783 · 2025 $112
Food & beverage: $112
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
Products named: FASENRA, OFEV, TRELEGY ELLIPTA, NUCALA.
Industry payments across PA — which companies pay providers there.
